Protagenic Therapeutics, Inc. (PTIX) Financials
PTIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.1 million | 1.1 million |
| March 31, 2026 | 3.7 million | 1.0 million |
| Dec. 31, 2025 | 2.1 million | 6.8 million |
| Sept. 30, 2025 | 2.1 million | 9.7 million |
PTIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -944298 | 67012 |
| March 31, 2026 | 262240 | ? |
| Dec. 31, 2025 | -410427 | 95942 |
| Sept. 30, 2025 | -1.5 million | -5019 |
PTIX Net Income
No data available :(
PTIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 565985 | - | - |
| March 31, 2026 | 1.5 million | - | - |
| Dec. 31, 2025 | 2.2 million | - | - |
| Sept. 30, 2025 | 2.7 million | - | - |
PTIX Shares Outstanding
PTIX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 109925 | 97980 | - |
| March 31, 2026 | 3293 | 80769 | 1.2 million | - |
| Dec. 31, 2025 | 6 | 153786 | 154817 | - |
| Sept. 30, 2025 | 3 | 273229 | 159915 | - |
PTIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 8312 |
| March 31, 2026 | - | 11501 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | 12572 |
PTIX
Price: $0.72
52 week price:
Earnings Per Share: -13.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6800
Market Capitalization: 1.4 million